Anti-LGI1 encephalitis is associated with unique HLA subtypes

Annals of Neurology

Volumn 81, Issue 2, 2017, Pages 183-192

  Kim, Tae Joon ^a   Lee, Soon Tae ^a   Moon, Jangsup ^a   Sunwoo, Jun Sang ^b   Byun, Jung Ick ^c   Lim, Jung Ah ^a   Shin, Yong Won ^a   Jun, Jin Sun ^a   Lee, Han Sang ^a   Lee, Woo Jin ^a   Yang, Ah Reaum ^a   Choi, Yunhee ^a   Park, Kyung Il ^d   Jung, Keun Hwa ^a   Jung, Ki Young ^a   Kim, Manho ^a,e   Lee, Sang Kun ^a   Chu, Kon ^a  

^a Seoul National University Hospital   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

^d Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; AUTOANTIBODY; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; LGI1 PROTEIN, HUMAN; PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ALLERGIC ENCEPHALITIS; ANTI LEUCINE RICH GLIOMA INACTIVATED 1 ENCEPHALITIS; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ENCEPHALITIS; GENETICS; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; ENCEPHALITIS; FEMALE; HAPLOTYPES; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; PROTEINS; YOUNG ADULT;

EID: 85013678975     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24860     Document Type: Article

References (49)

1. Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro Oncol 2014;16:771–778.
2. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391–404.
3. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–1098.
4. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776–785.
5. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734–2748.
6. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157–165.
7. Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013;265:75–81.
8. Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 2014;261:1695–1705.
9. Lee WJ, Lee ST, Moon J, et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 2016;13:824–832.
10. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013;33:18161–18174.
11. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014;75:317–323.
12. Armangue T, Moris G, Cantarin-Extremera V, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 2015;85:1736–1743.
13. Sollid LM, Pos W, Wucherpfennig KW. Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. Curr Opin Immunol 2014;31:24–30.
14. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704–706.
15. de Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009;61:1287–1296.
16. International MHC, Autoimmunity Genetics N, Rioux JD, et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A 2009;106:18680–18685.
17. Noble JA, Erlich HA. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med 2012;2:a007732.
18. Mignot E, Hayduk R, Black J, et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012–1020.
19. Hor H, Kutalik Z, Dauvilliers Y, et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010;42:786–789.
20. Niks EH, Kuks JB, Roep BO, et al. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology 2006;66:1772–1774.
21. Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 2014;13:575–586.
22. Lee WJ, Lee ST, Byun JI, et al. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology 2016;86:1683–1691.
23. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67–76.
24. Moon J, Park HK, Chu K, et al. The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population. Epilepsia 2015;56:e161–e167.
25. Kim SH, Lee KW, Song WJ, et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 2011;97:190–197.
26. Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 2005;65:437–447.
27. Lee KW, Jung YA, Oh DH. Diversity of HLA-DQA1 gene in the Korean population. Tissue Antigens 2007;69(suppl 1):82–84.
28. Lee KW, Jung YA. Refined information on alleles belonging to the C*07:01/07:06/07:18 group in the Korean population. Hum Immunol 2011;72:723–726.
29. Excoffier L, Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010;10:564–567.
30. Imanishi T, Akaza T, Kimura A, et al. Estimation of allele and haplotype frequencies for HLA and complement loci. Tsuji K, Aizawa M, Sasazuki T, et al. eds. HLA 1991, Vol. 1. Oxford, UK: Oxford University Press; 1992.
31. Nielsen M, Lundegaard C, Worning P, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003;12:1007–1017.
32. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001;17:1236–1237.
33. Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009;10:296.
34. Peters B, Bui HH, Frankild S, et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2006;2:e65.
35. Lin HH, Zhang GL, Tongchusak S, et al. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 2008;9(suppl 12):S22.
36. Wang P, Sidney J, Kim Y, et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 2010;11:568.
37. UniProt C. UniProt: a hub for protein information. Nucleic Acids Res 2015;43:D204–D212.
38. Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 2014;42:W252–W258.
39. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–1612.
40. Gunther S, Schlundt A, Sticht J, et al. Bidirectional binding of invariant chain peptides to an MHC class II molecule. Proc Natl Acad Sci U S A 2010;107:22219–22224.
41. Singh S, Singh H, Tuknait A, et al. PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol Direct 2015;10:73.
42. Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–2791.
43. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–461.
44. Heap GA, Weedon MN, Bewshea CM, et al. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat Genet 2014;46:1131–1134.
45. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18–27.
46. Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000;343:782–786.
47. Seldin MF. The genetics of human autoimmune disease: a perspective on progress in the field and future directions. J Autoimmun 2015;64:1–12.
48. Verhelst H, Verloo P, Dhondt K, et al. Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster. Eur J Paediatr Neurol 2011;15:163–166.
49. de Wit J, Hong W, Luo L, Ghosh A. Role of leucine-rich repeat proteins in the development and function of neural circuits. Annu Rev Cell Dev Biol 2011;27:697–729.